{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:05:21Z","timestamp":1768712721204,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS051715"],"award-info":[{"award-number":["NS051715"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AG030539"],"award-info":[{"award-number":["AG030539"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AG044817"],"award-info":[{"award-number":["AG044817"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["11-205561"],"award-info":[{"award-number":["11-205561"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["14-283969"],"award-info":[{"award-number":["14-283969"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003750","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbadis.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T18:39:33Z","timestamp":1411929573000},"page":"2457-2467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PA","title":["Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration"],"prefix":"10.1016","volume":"1842","author":[{"given":"Krysti","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ghiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agueda","family":"Rostagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.09.010_bb0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-2001-3110","article-title":"Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia","volume":"3","author":"Ghiso","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0030","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers \u2014 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0040","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12035-012-8246-0","article-title":"Protein homeostasis, aging and Alzheimer's disease","volume":"46","author":"Morawe","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0060","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.ddtec.2012.04.001","article-title":"Animal models of Alzheimer's disease and drug development","volume":"10","author":"Laurijssens","year":"2013","journal-title":"Drug Discov. Today Technol."},{"issue":"Pt 3","key":"10.1016\/j.bbadis.2014.09.010_bb0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/brain\/113.3.721","article-title":"Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation","volume":"113","author":"Plant","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2000.tb06908.x","article-title":"Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13","volume":"920","author":"Ghiso","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004010050970","article-title":"Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation","volume":"97","author":"Revesz","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-3639.2006.tb00563.x","article-title":"Genetic alterations of the BRI2 gene: familial British and Danish dementias","volume":"16","author":"Ghiso","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/21637","article-title":"A stop-codon mutation in the BRI gene associated with familial British dementia","volume":"399","author":"Vidal","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0090","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00018-005-5092-5","article-title":"Chromosome 13 dementias","volume":"62","author":"Rostagno","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0095","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/14783","article-title":"Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia","volume":"2","author":"Kim","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0100","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1074\/jbc.M108739200","article-title":"Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-5793(04)00300-X","article-title":"Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions","volume":"563","author":"Schilling","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1515\/BC.2008.111","article-title":"Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution","volume":"389","author":"Schilling","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","article-title":"Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain","volume":"215","author":"Saido","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0120","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi990563r","article-title":"The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta","volume":"38","author":"He","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0125","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","article-title":"N-terminal pyroglutamate formation of Abeta38 and Abeta40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation","volume":"121","author":"Schlenzig","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-Abeta 3\u201342 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11357-012-9403-0","article-title":"Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Abeta pathology at the lysosome","volume":"35","author":"De Kimpe","year":"2013","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000353634","article-title":"Pyroglutamate-modified amyloid-beta protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain","volume":"14","author":"Wu","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-121945","article-title":"Oligomeric pyroglutamate amyloid-beta is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy","volume":"35","author":"Wirths","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00702-009-0314-x","article-title":"Pyroglutamate Abeta pathology in APP\/PS1KI mice, sporadic and familial Alzheimer's disease cases","volume":"117","author":"Wirths","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0160","doi-asserted-by":"crossref","first-page":"34186","DOI":"10.1074\/jbc.M501694200","article-title":"beta-Amyloid is different in normal aging and in Alzheimer disease","volume":"280","author":"Piccini","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","article-title":"Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models","volume":"183","author":"Frost","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0170","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1021\/bi002287i","article-title":"Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia","volume":"40","author":"El Agnaf","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0175","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"Schlenzig","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0180","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jmb.2003.09.001","article-title":"pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia","volume":"333","author":"Srinivasan","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0185","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.neurobiolaging.2012.11.014","article-title":"Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias","volume":"34","author":"Saul","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/bst0300557","article-title":"Properties of neurotoxic peptides related to the BRI gene","volume":"30","author":"Austen","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/jmbi.2001.4743","article-title":"Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils","volume":"310","author":"El Agnaf","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1096\/fj.09-139584","article-title":"Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls","volume":"24","author":"Fossati","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0205","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0210","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00018-009-8746-x","article-title":"Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells","volume":"66","author":"Viana","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb1001203","article-title":"ANS binding reveals common features of cytotoxic amyloid species","volume":"5","author":"Bolognesi","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nprot.2006.62","article-title":"Blue native PAGE","volume":"1","author":"Wittig","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0230","doi-asserted-by":"crossref","first-page":"43909","DOI":"10.1074\/jbc.M105956200","article-title":"Systemic amyloid deposits in familial British dementia","volume":"276","author":"Ghiso","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0235","first-page":"277","article-title":"Chromosome 13 dementia syndromes as models of neurodegeneration","volume":"8","author":"Ghiso","year":"2001","journal-title":"Amyloid Int. J. Experiment. Clin. Invest."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20130652","article-title":"Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid beta and the Asn23 Iowa mutation","volume":"456","author":"Fossati","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0245","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1038\/cddis.2012.55","article-title":"TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Abeta","volume":"3","author":"Fossati","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0250","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0255","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1074\/mcp.M900526-MCP200","article-title":"Mass estimation of native proteins by blue native electrophoresis: principles and practical hints","volume":"9","author":"Wittig","year":"2010","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0260","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1002\/pmic.200800017","article-title":"Features and applications of blue-native and clear-native electrophoresis","volume":"8","author":"Wittig","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0265","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2119\/molmed.2011.00366","article-title":"beta-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons","volume":"18","author":"Nicholson","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-011-2291-7","article-title":"Neuroprotection of paliperidone on SH-SY5Y cells against beta-amyloid peptide(25\u201335), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death","volume":"217","author":"Yang","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0275","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1073\/pnas.93.7.2996","article-title":"Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein","volume":"93","author":"Davis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1471-4159.2003.02134.x","article-title":"Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia","volume":"88","author":"Gibson","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2008.04.169","article-title":"Form and dimensions of aggregates dictate cytotoxicities of Danish dementia peptides","volume":"372","author":"Surolia","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0290","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","article-title":"Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0300","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbamem.2013.06.026","article-title":"Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols","volume":"1828","author":"Camilleri","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0305","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.cdd.4401476","article-title":"Apoptosome inactivation rescues proneural and neural cells from neurodegeneration","volume":"11","author":"Cozzolino","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0891-5849(03)00244-2","article-title":"Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis","volume":"35","author":"Tamagno","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0320","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10541-005-0102-7","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"70","author":"Andreyev","year":"2005","journal-title":"Biochem. Biokhim."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0325","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid beta-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0330","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/ars.2012.4905","article-title":"Regulation of the intrinsic apoptosis pathway by reactive oxygen species","volume":"19","author":"Wu","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0335","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.2174\/092986709789378206","article-title":"Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein","volume":"16","author":"Caroppi","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0340","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yexcr.2012.02.013","article-title":"The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome","volume":"318","author":"Wurstle","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.str.2013.02.024","article-title":"Apoptosome structure, assembly, and procaspase activation","volume":"21","author":"Yuan","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0350","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1471-4159.2012.07927.x","article-title":"Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis","volume":"123","author":"Sabirzhanov","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0355","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1460-9568.2011.07891.x","article-title":"Altered apoptotic responses in neurons lacking RhoB GTPase","volume":"34","author":"Barberan","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0360","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1007\/s00018-011-0667-9","article-title":"Autophagic activity in cortical neurons under acute oxidative stress directly contributes to cell death","volume":"68","author":"Higgins","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0365","first-page":"197","article-title":"Amyloid fibril protein nomenclature","volume":"9","author":"Westermark","year":"2002","journal-title":"Amyloid Int. J. Experiment. Clin. Invest."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0370","first-page":"1","article-title":"Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis","volume":"12","author":"Westermark","year":"2005","journal-title":"Amyloid Int. J. Experiment. Clin. Invest."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0375","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","article-title":"Amyloidosis and Alzheimer's disease","volume":"54","author":"Ghiso","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0380","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature01891","article-title":"Rationalization of the effects of mutations on peptide and protein aggregation rates","volume":"424","author":"Chiti","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0385","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-2004-6311","article-title":"The amyloid hypothesis and the clearance and degradation of Alzheimer's beta-peptide","volume":"6","author":"LeVine","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0390","first-page":"539","article-title":"Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of \u2018aging\u2019?","volume":"38","author":"Moro","year":"2010"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0925-4439(98)00014-3","article-title":"Irreversible dimerization\/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease","volume":"1406","author":"Kuo","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0400","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0405","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0410","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1021\/jp412743s","article-title":"Pyroglutamylated amyloid-beta peptide reverses cross beta-sheets by a prion-like mechanism","volume":"118","author":"Matos","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0415","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","article-title":"The p75 neurotrophin receptor promotes amyloid-beta(1\u201342)-induced neuritic dystrophy in vitro and in vivo","volume":"29","author":"Knowles","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2014.09.010_bb0420","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.09.010_bb0425","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","article-title":"Amyloid ion channels: a common structural link for protein-misfolding disease","volume":"102","author":"Quist","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914002919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914002919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T14:29:00Z","timestamp":1565879340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914002919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0925443914002919"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.09.010","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}